Primary Site >> Colorectal Cancer
Gene >> RASA4
|
|
|
|
|
|---|---|---|---|---|
|
Ref: Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients. PMID: 19152449 |
Ref: [Expression profile of genes associated with the histaminergic system estimated by oligonucleotide microarray analysis HG-U133A in women with endometrial adenocarcinoma]. PMID: 24783427 Ref: Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial. PMID: 24942275 |
Ref: Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial. PMID: 25851630 |
Ref: Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX. PMID: 27002107 |
Ref: RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial. PMID: 28950295 |